Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 8
2012 5
2013 13
2014 12
2015 5
2016 5
2017 3
2018 5
2019 1
2020 4
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
cAMP Buffering via Liquid-Liquid Phase Separation.
Zaccolo M. Zaccolo M. Function (Oxf). 2020 Dec 26;2(1):zqaa048. doi: 10.1093/function/zqaa048. eCollection 2021. Function (Oxf). 2020. PMID: 33511352 Free PMC article. No abstract available.
The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
Kalla M, Hao G, Tapoulal N, Tomek J, Liu K, Woodward L; ‘Oxford Acute Myocardial Infarction (OxAMI) Study’; Dall'Armellina E, Banning AP, Choudhury RP, Neubauer S, Kharbanda RK, Channon KM, Ajijola OA, Shivkumar K, Paterson DJ, Herring N. Kalla M, et al. Eur Heart J. 2020 Jun 14;41(23):2168-2179. doi: 10.1093/eurheartj/ehz852. Eur Heart J. 2020. PMID: 31834357 Free PMC article.
Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.
Herring N, Tapoulal N, Kalla M, Ye X, Borysova L, Lee R, Dall'Armellina E, Stanley C, Ascione R, Lu CJ, Banning AP, Choudhury RP, Neubauer S, Dora K, Kharbanda RK, Channon KM; Oxford Acute Myocardial Infarction (OxAMI) Study. Herring N, et al. Eur Heart J. 2019 Jun 21;40(24):1920-1929. doi: 10.1093/eurheartj/ehz115. Eur Heart J. 2019. PMID: 30859228 Free PMC article.
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).
Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, Edelmann F, Filippatos G, Gruson D, Ikonomidis I, Lhommel R, Mahmod M, Neubauer S, Persu A, Gerber BL, Piechnik S, Pieske B, Pieske-Kraigher E, Pinto F, Ponikowski P, Senni M, Trochu JN, Van Overstraeten N, Wachter R, Balligand JL. Pouleur AC, et al. ESC Heart Fail. 2018 Oct;5(5):830-841. doi: 10.1002/ehf2.12306. Epub 2018 Jun 22. ESC Heart Fail. 2018. PMID: 29932311 Free PMC article. Clinical Trial.
57 results